|
[posting]56433281[/posting]also hab nochmal nachgesehen, leider keine konkrete Info wie sich die Meilensteine zusammensetzen; ich gehe aber eher nicht davon aus, dass 187 mio auf einmal fällig werden, sondern aufgeteilt nach Regionen/Indikationen. Ein kleiner Hinweis darauf mag sein "regulatory approval milestones", also Mehrzahl. Under the terms of the MorphoSys Agreement, we received a $13 million upfront payment and $3 million for development milestone payments in 2013. If certain developmental, regulatory and sales milestones are achieved, we are also eligible to receive up to an additional $299 million in milestone payments which are comprised as follows: $62.0 million in clinical development milestones, $187 million in regulatory approval milestones and $50 million of aggregate milestone payments for the achievement of certain product sale goals. If licensed products are commercialized, we are also entitled to receive tiered royalties in the high single ‑ digit to low ‑ teen percent range. |
|
| aus der Diskussion: | Antikörper-Optimierung durch Xencor |
| Autor (Datum des Eintrages): | PathFinder2 (12.12.17 19:40:08) |
| Beitrag: | 99 von 268 (ID:56434235) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |